GE Healthcare has launched Research Circle Technology (RCT), a new research-oriented subsidiary dedicated to developing metabolic imaging technology.
RCT will create alliances between GE scientists and leading universities around the world, giving researchers easier access to GE technology, according to the company. One early partner is the Surbeck Laboratory for Advanced Imaging at the University of California, San Francisco, which has published the results of a study using GE's carbon-13 technology for prostate cancer. The findings were presented at the World Molecular Imaging Congress (WMIC) in San Diego this week.
RCT will sell SpinLab polarizers, as well as provide licensing framework for partners to continue to develop metabolic imaging applications.
